ClinicalTrials.govpublic full text
TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis
atopic dermatitis, pruritus, eczema, topical therapy, jak inhibitor, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 1010588
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.